AmeriPharma’s premier pharmacy services are available in multiple states throughout the US.
Mon - Fri: 9:00AM - 10:00PM Sat - Sun: Closed

Related Posts

Welcome to Infusion Center

Get Financial Relief Now

Apply for Ruxience Copay Assistance

Free service matches you with top copay assistance programs

Specialists assist you throughout the application process

Get automated updates on your funding status

Over $55 million secured for our patients to date

How Much Can You Save?

Speak With a Copay Assistance Specialist

We accept Medicare, multi-state Medicaid, Medi-Cal, Blue Shield, and most private insurances.

Medi-Cal logo
LegitScript approved

Get Started in Minutes

How Ruxience Copay Assistance Works

plus icon with transparent background

1 – Check Your Coverage/Benefits Verification

Our team of expert billers finds the best avenues of coverage that minimize out-of-pocket costs.

Rx icon

2 – Transfer Prescription to AmeriPharma

We process your prescription by working with your previous pharmacy or prescriber, making the transition quick and easy.

document icon with transparent background

3 – Prior Authorization

Our team of specialists obtains approval from your insurance companies within 24 to 72 hours.

document and personnel icon with transparent background

4 – Copay Assistance & Financial Aid

We secure financial aid and decrease copays, out-of-pocket expenses, and high deductibles. To date, AmeriPharma Specialty Care has secured $55 million in financial assistance for our patients.

3 hands and plus icon with transparent background

5 – Nursing Care Coordination

AmeriPharma puts your schedule and home environment first when scheduling and coordinating one of our specialized nurses for your in-home infusions.

box icon with transparent background

6 – Delivery Coordination

Medications are always delivered in strict compliance with the specific requirements for immune globulin shipping. Next-day and overnight cold-chain deliveries are coordinated around your schedule.

Speak With a Specialist

We accept Medicare, multi-state Medicaid, Medi-Cal, Blue Shield, and most private insurances. Call us to find out more about your coverage.

What Is Ruxience? 

Ruxience is a CD20-directed cytolytic antibody used to treat certain autoimmune diseases and types of cancer. It is an FDA- approved biosimilar to Rituxan (rituximab). 

Patients should be under the care of a clinician experienced with using rituximab for the specific indication they are being treated for.

Pretreatment immunizations

When feasible, administer appropriate immunizations 4 weeks or more before starting therapy.

Prophylaxis against opportunistic infection and viral reactivation may be warranted during and up to 12 months after completion of rituximab therapy.

Premedication

The manufacturer’s labeling recommends premedicating about 30 minutes prior to administration with acetaminophen, an antihistamine, and methylprednisolone 100 mg (IV) or equivalent for adults.

Schedule a Consultation

We accept Medicare, multi-state Medicaid, Medi-Cal, Blue Shield, and most private insurances. Call us to find out more about your coverage.

What is Ruxience Used to Treat?

Ruxience is used to treat patients with:

  • Non-Hodgkin’s Lymphoma (NHL)     
    • Relapsed or refractory, follicular or low grade, CD20-positive B-cell NHL as a single agent.
    • Previously untreated CD20-positive, follicular, B-cell NHL in combination with first-line chemotherapy. Also used in patients achieving a partial or complete response to a rituximab product in combination with chemotherapy, as a single-agent maintenance therapy.
    • Non-progressing (including stable disease), CD20-positive, low-grade B-cell NHL as a single agent after first-line cyclophosphamide, vincristine, and prednisone chemotherapy.
    • Previously untreated diffuse large B-cell, CD20-positive NHL in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or another anthracycline-based chemotherapy regimen.
  • Chronic Lymphocytic Leukemia (CLL) 
    • Previously treated and previously untreated CD20-positive CLL in combination with fludarabine and cyclophosphamide.
  • Granulomatosis with Polyangiitis (GPA) (Wegener’s Granulomatosis) and Microscopic Polyangiitis (MPA) in adult patients in combination with glucocorticoids.
  • Multiple Sclerosis
  • Rheumatoid Arthritis

Copay and Financial Assistance

AmeriPharma Specialty Care alleviates financial burdens for patients and their families

Advanced software icon
Advanced software locates funding sources to match you with top-dollar foundation programs
Copay assistance icon
One of our copay assistance specialists will assist with the application process
Funding status icon
Automatic updates will be sent to you and your physician on the status of the funding

Speak With a Specialist

We accept Medicare, multi-state Medicaid, Medi-Cal, Blue Shield, and most private insurances. Call us to find out more about your coverage.

Ruxience Side Effects

  • Feeling tired or weak
  • Headache
  • Upset stomach or throwing up
  • Stomach pain or diarrhea
  • Runny or stuffy nose
  • Muscle spasm
  • Back, muscle, or joint pain
  • Trouble sleeping
  • Night sweats
  • Throat irritation
  • Flushing
  • Anxiety

Schedule a Consultation

We accept Medicare, multi-state Medicaid, Medi-Cal, Blue Shield, and most private insurances. Call us to find out more about your coverage.

Ruxience Dosing Information

Immune thrombocytopenia (alternative agent) (off-label use):

IV dose: 375 mg/m2 once weekly for 4 doses.

Rheumatoid arthritis (Rituxan and rituximab biosimilars) (alternative agent):

Initial IV dose: 1 g once every 2 weeks for 2 doses; subsequent courses of 1 g once every 2 weeks for 2 doses may be administered every 24 weeks or as indicated based on clinical evaluation, but no sooner than every 16 weeks.

Multiple sclerosis (off-label use):

IV dose: 1 g once every 2 weeks for 2 doses; then repeat 1 g once every 6 to 12 months. Alternatively, administer 500 mg to 1 g once every 6 to 12 months.

Myasthenia gravis, refractory or muscle-specific tyrosine kinase antibody-positive (off-label use):

IV dose: 1 g once every 2 weeks for 2 doses or 375 mg/m2 once weekly for 4 weeks; full or partial course may be repeated at preplanned intervals (e.g., 6 months) or as clinically indicated based on symptoms and lymphocyte recovery.

How Much Can You Save?

Speak With a Copay Assistance Specialist

© 2024 AmeriPharma Specialty Care. All Rights Reserved.  132 S. Anita Dr. 2nd Floor, Orange, CA 92868. Privacy Policy | Terms of use